Travere Therapeutics's Earnings: A Preview

Travere Therapeutics TVTX will release its quarterly earnings report on Thursday, 2025-05-01. Here's a brief overview for investors ahead of the announcement.

Analysts anticipate Travere Therapeutics to report an earnings per share (EPS) of $-0.36.

The market awaits Travere Therapeutics's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.

It's important for new investors to understand that guidance can be a significant driver of stock prices.

Overview of Past Earnings

Last quarter the company missed EPS by $0.09, which was followed by a 6.79% drop in the share price the next day.

Here's a look at Travere Therapeutics's past performance and the resulting price change:

Travere Therapeutics Share Price Analysis

Shares of Travere Therapeutics were trading at $20.08 as of April 29. Over the last 52-week period, shares are up 236.04%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

To track all earnings releases for Travere Therapeutics visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.